ORIGINAL RESEARCH
Published on 28 Aug 2025
Role of 18F-AlF-NOTATATE PET/CT in selecting pediatric neuroblastoma candidates for 177Lu-DOTATATE peptide receptor radionuclide therapy
doi 10.3389/fmed.2025.1615136
- 2,128 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
Development and Validation of New Molecular Probes of Nuclear Medicine and New Targets of Nuclear Drugs in Cancers
2,099
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 27 Aug 2025
Clozapine Responsible for In vivo Imaging and Pharmacological Effect of Clozapine-N-oxide (CNO) in Murine DREADD Models
doi 10.3389/fphar.2025.1671065
- 164 views
ORIGINAL RESEARCH
Published on 03 Jul 2025
The value of 18F-AlF-NOTATATE PET/CT in restaging high-risk neuroblastoma after chemotherapy
doi 10.3389/fmed.2025.1596272
- 1,401 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway
doi 10.3389/fphar.2025.1572621
- 934 views
ORIGINAL RESEARCH
Published on 15 May 2025
Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer
doi 10.3389/fphar.2025.1576587
- 1,102 views
- 1 citation
REVIEW
Published on 14 May 2025
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
doi 10.3389/fphar.2025.1593380
- 2,439 views
REVIEW
Published on 08 May 2025
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives
doi 10.3389/fphar.2025.1559236
- 2,086 views
ORIGINAL RESEARCH
Published on 10 Apr 2025
Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer
doi 10.3389/fonc.2025.1580166
- 924 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Medicine
- 3.0 impact factor
- 6.0 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: